SUSAN CHAPMAN: Open Payments
NPI 1629036181 · FRANKLIN, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$349 in 16 payments from 8 companies in 2025. Trend: 2023 $2,479 · 2024 $764 · 2025 $349
Food & beverage: $349
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 7 | $176 |
| Vanda Pharmaceuticals Inc. | 2 | $47 |
| Neurocrine BioSciences, Inc. | 2 | $42 |
| Axsome Therapeutics, Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Alkermes, Inc. | 1 | $15 |
| ABBVIE INC. | 1 | $14 |
Products named: SPRAVATO, FANAPT, INGREZZA, Auvelity, TRINTELLIX, REXULTI, ARISTADA, VRAYLAR.
Industry payments across WI — which companies pay providers there.
